SEC Form 4 · accession 0000914190-16-000690
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman David Eansor
Officer — SVP - Novus Biologicals
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 1, 2016 | F | 533 | $112.24 | D | 3,936 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (Right to Buy)F4 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 9,375 | 9,375 | D |
| Restricted Stock UnitsF5,F4 | — | holding | — | — | — | — | — | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit grant by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
- F2Includes 1,666 shares of restricted stock units that vest on 7/1/17.
- F33,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F4Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.
- F5Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.